CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
C-Leg 4 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02765035
NCT02765035N/ACompleted

A Randomized, Blinded, Cross-over Trial to Evaluate the Safety, Functional Mobility and Satisfaction of the Microprocessor Controlled Prosthetic Knee Component C-Leg 4 in Transfemoral Amputees

Otto Bock Healthcare Products GmbH·interventional·Posted May 6, 2016·Updated Oct 14, 2021

In Brief

A clinical study evaluating C-Leg 4 and C-Leg 3 for Lower Limb Amputation Above Knee (Injury). Completed, enrolled 18 participants across 2 sites in 2 countries.

Detailed Summary

The aim of this post-market study is to confirm that the microprocessor controlled prosthetic knee components (C-Leg 3 and C-Leg 4) in comparison to mechanical knee joints can bring additional benefit to the users primarily on level walking and secondarily in safety, stair and hill mobility, activities of daily living, satisfaction and preference.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 6, 2016
Enrollment StartApr 1, 2016
Primary CompletionMay 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.2 years ago

Interventions

C-Leg 4device

Microprocessor Controlled Knee

C-Leg 3device

Microprocessor Controlled Knee